Skip to main content
PLRZ logo

Polyrizon Ltd.

PLRZNASDAQHealthcareBiotechnology

$10.00Today:- (-)1Y +58.14%

As of Oct 16, 2026 close

Market cap
$18.11M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.88$18.20
Volume (live)
-
Avg. volume (3M)
41.70K

Polyrizon (PLRZ) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Polyrizon reported total assets of $21.44M and total liabilities of $443.00K. Shareholders' equity was $20.99M, up 297.2% from $5.29M a year earlier. Total debt stood at $0.00 against $12.46M in cash and short-term investments, a net cash position of $12.46M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Polyrizon Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Polyrizon Ltd. (PLRZ) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents1.312.550.000.040.520.01
Short-Term Investments10.380.000.040.000.000.00
Cash & Short-Term Investments12.462.550.040.040.520.01
Accounts Receivable0.000.000.000.000.000.00
Inventory0.000.000.000.000.000.00
Other Current Assets0.400.100.010.020.020.01
Total Current Assets12.862.650.050.050.540.02
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.010.020.020.01
Intangible Assets2.552.880.000.000.000.00
Other Non-Current Assets6.020.000.490.480.130.00
Total Non-Current Assets8.582.890.510.500.140.01
Total Assets21.445.550.560.550.690.02
Current Liabilities
Accounts Payable0.000.000.000.000.000.00
Short-Term Debt0.000.000.200.000.000.00
Accrued Liabilities0.440.220.200.140.170.01
Other Current Liabilities0.440.260.301.200.690.01
Total Current Liabilities0.440.260.501.200.690.01
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.000.00
Other Non-Current Liabilities0.000.000.250.000.000.00
Total Non-Current Liabilities0.000.000.250.000.000.00
Total Liabilities0.440.260.751.200.690.01
Stockholders' Equity
Common Stock0.000.000.000.000.330.05
Retained Earnings-8.40-5.07-3.52-2.92-2.14-1.43
Accumulated Other Comprehensive Income0.000.00-0.200.000.000.00
Additional Paid-in Capital29.4010.353.532.021.571.15
Shares Outstanding1.610.000.000.00--
Total Stockholders' Equity20.995.290.06-0.650.000.02
Total Liabilities & Equity21.445.550.560.550.690.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Polyrizon Balance Sheet

How much debt does Polyrizon have?

Polyrizon had total debt of $0.00 as of Dec 31, 2025, against $12.46M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Polyrizon's total assets?

Polyrizon reported total assets of $21.44M as of Dec 31, 2025, up 286.5% from $5.55M a year earlier. Total liabilities were $443.00K.

What is Polyrizon's shareholders' equity?

Polyrizon's shareholders' equity was $20.99M as of Dec 31, 2025, or about $13.05 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition